We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final FDA Guidance on Trial Monitoring to Give More Detail on Creating Plans
Final FDA Guidance on Trial Monitoring to Give More Detail on Creating Plans
September 28, 2012
An upcoming final FDA guidance on risk-based monitoring of clinical investigations will include more specifics for drugmakers on developing monitoring plans, as the industry has requested.